A Clinical Observation of Cf-252 Intracavitary Radiation Combined with External-beam Irradiation in the Treatment of Esophageal Carcinoma

盖晓惠,高献书,刘惠明,周志国,张戈妹,贾喜堂,万钧

DOI: https://doi.org/10.3969/j.issn.1001-5930.2011.04.020

2011-01-01

Abstract:Objective This study is to evaluate the therapeutic efficacy and the untoward reaction external-beam irradiation combined with Cf-252 intracavitary radiation in the treatment of esophageal carcinoma in a clinical randomized trial.Methods Fifty patients of locally moderate and advanced esophageal carcinoma were randomized into two groups:external beam combined with Cf-252 intracavitary twice group(EBIR-2) and external beam combined with Cf-252 intracavitary three times group(EBIR-3).In EBIR-2 group,22 patients were first treated with conventional fractionated radiation to a dose of 40 Gy over 4 weeks,then with external and intracavitary radiation concomitantly(5.0 Gy per fraction,once a week to 10 Gy in 2 fractions).The total dose of external irradiation was 50 Gy.In EBIR-3 group,28 patients were first treated with conventional fractionated radiation to a dose of 30Gy over 3 weeks,then with external and intracavitary radiation concomitantly(3.5 Gy per fraction,once a week to 10.5Gy in 3 fractions),and the total dose of external irradiation also was 50 Gy.Results The 1-,3-and 5-year local control rate were 72.73%、58.18%、48.48% and 77.52%、46.96%、41.74% in EBIR-2 group and EBIR-3 group,respectively.The 1-,3-and 5-year survival rates were 81.82%、40.91%、27.27% in EBIR-2 group and 75.0%、32.14%、28.57% in EBIR-3 group.Higher acute esophagitis rate was observed both in EBIR-2 and EBIR-3 group,and the rate was 90.9% and 92.9%,respectively.Late esophagitis rate was 81.8% and 50.0% in EBIR-2 and EBIR-3 group.Conclusion The survival rate and local control rate were similar in two groups.But the late effect in EBIR-2 group was higher than EBIR-3 group.